Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecules"
DOI: 10.3390/molecules27196500
Abstract: The tropomyosin receptor kinases (TRKs) have been validated as effective targets in anticancer drug discovery. Two first-generation TRK inhibitors have been approved into market and displayed an encouraging therapeutic response in cancer patients harboring TRK…
read more here.
Keywords:
jnd4135 new;
trk;
resistance;
trk inhibitor ... See more keywords